Myofibrillar myopathies due to a novel mutation in exon 8 of the LDB3 gene
International Journal of Rheumatic Diseases · 2024
DOI: 10.1111/1756-185x.15036 ↗Kurz gefasst
Fallbericht in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Hongjia Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, C…. Hauptthemen laut MEDLINE: Myofibrils, Myopathies, Structural, Congenital. Die Arbeit nennt 13 Literaturangaben. Gefördert von: Science and Technology Department of Sichuan Province, Sichuan Medical Association, Department of Science and Technology of Sichuan Province.
Abstract (Originalsprache)
Myofibrillar myopathies (MFMs) are a group of genetically heterogeneous diseases affecting the skeletal and cardiac muscles. Myofibrillar myopathies are characterized by focal lysis of myogenic fibers and integration of degraded myogenic fiber products into inclusion bodies, which are typically rich in desmin and many other proteins. Herein, we report a case of a 54‐year‐old woman who experienced bilateral thigh weakness for over three years. She was diagnosed with MFMs based on muscle biopsy findings and the presence of a novel mutation in exon 8 of the LDB3 gene. Myofibrillar myopathies caused by a mutation in the LDB3 gene are extremely uncommon and often lack distinct clinical characteristics and typically exhibit a slow disease progression. When considering a diagnosis of MFMs, particularly in complex instances of autosomal dominant myopathies where muscle biopsies do not clearly indicate MFMs, it becomes crucial for clinicians to utilize genetic test as a diagnostic tool.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology and Immunology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Fifth Internal Medicine, Chengdu Pidu District Hospital of Traditional Chinese Medicine, Chengdu, China.
- Department of Rheumatology and Immunology, Chinese Academy of Sciences Sichuan Translational Medicine Research Hospital, Chengdu, China.
- Department of Neurology, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
ORCID-Profile: Hongjia Du, Yan Chen
Förderung
- Science and Technology Department of Sichuan Province
- Sichuan Medical Association
- Department of Science and Technology of Sichuan Province
Zitieren
APA
Du, H., Chen, Y., Zeng, L., Wu, R., Wu, T., & Zhu, J. (2024). Myofibrillar myopathies due to a novel mutation in exon 8 of the LDB3 gene. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15036
Vancouver
Du H, Chen Y, Zeng L, Wu R, Wu T, Zhu J. Myofibrillar myopathies due to a novel mutation in exon 8 of the LDB3 gene. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15036
BibTeX
@article{Du2024,
author = {Du, Hongjia and Chen, Yan and Zeng, Li and Wu, Rui and Wu, Tong and Zhu, Jing},
title = {Myofibrillar myopathies due to a novel mutation in exon 8 of the LDB3 gene},
journal = {International Journal of Rheumatic Diseases},
year = {2024},
doi = {10.1111/1756-185x.15036}
}
EUVIMED